Guizhou Yibai Pharmaceutical Co., Ltd. (SHA:600594)
China · Delayed Price · Currency is CNY 3.130
-0.080 (-2.49%)
Nov 13, 2026, 3:00 PM CST
SHA:600594 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 402.69 | 447.13 | 521.01 | 699.47 | 592.36 | 379.63 |
Short-Term Investments | - | 20.06 | 20 | - | - | - |
Cash & Short-Term Investments | 402.69 | 467.2 | 541.01 | 699.47 | 592.36 | 379.63 |
Cash Growth | -32.17% | -13.64% | -22.66% | 18.08% | 56.04% | -47.15% |
Accounts Receivable | 262.16 | 376.97 | 528.94 | 692.32 | 722.23 | 698.66 |
Other Receivables | 33.19 | 31.88 | 19.23 | 53.84 | 56.42 | 38.42 |
Receivables | 295.35 | 408.86 | 548.17 | 746.16 | 778.65 | 737.07 |
Inventory | 495.02 | 546.9 | 607.77 | 586.65 | 625.08 | 554.63 |
Other Current Assets | 70.52 | 24.76 | 53.08 | 36.87 | 44.54 | 48.65 |
Total Current Assets | 1,264 | 1,448 | 1,750 | 2,069 | 2,041 | 1,720 |
Property, Plant & Equipment | 1,399 | 1,474 | 1,648 | 1,755 | 1,827 | 1,709 |
Long-Term Investments | 35.8 | 35.9 | 36.41 | 36.66 | 37.46 | 38.27 |
Goodwill | - | - | 131.26 | 164.04 | 164.04 | 777.66 |
Other Intangible Assets | 302.08 | 312.29 | 319.56 | 330.89 | 362.03 | 378.54 |
Long-Term Deferred Tax Assets | 81.54 | 77.81 | 90.34 | 55.58 | 229.96 | 202.28 |
Long-Term Deferred Charges | 64.48 | 77.82 | 103.47 | 123.13 | 145.72 | 169.81 |
Other Long-Term Assets | 13.63 | 16.18 | 20.58 | 62.42 | 63.17 | 72.4 |
Total Assets | 3,160 | 3,442 | 4,100 | 4,597 | 4,870 | 5,068 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 61.05 | 97.58 | 117.98 | 124.54 | 133.25 | 108.47 |
Accrued Expenses | 36.15 | 58.7 | 57.79 | 72.43 | 103.61 | 86.57 |
Short-Term Debt | 408.87 | 413.93 | 380.93 | 446.05 | 537.11 | 454.45 |
Current Portion of Long-Term Debt | 168.58 | 162.69 | 227.68 | 115.05 | 162.15 | 120.15 |
Current Portion of Leases | - | 5.19 | 8.98 | 13.97 | 15.37 | 9.16 |
Current Income Taxes Payable | 18.67 | 3.97 | 8.85 | 7.54 | 21.07 | 47.42 |
Current Unearned Revenue | 19.73 | 24.28 | 27.12 | 29.52 | 67.51 | 54.15 |
Other Current Liabilities | 105.1 | 142.54 | 119.68 | 120.49 | 132.64 | 199.01 |
Total Current Liabilities | 818.16 | 908.88 | 949.01 | 929.59 | 1,173 | 1,079 |
Long-Term Debt | 85.71 | 100.14 | 307.52 | 387.22 | 343.04 | 315.93 |
Long-Term Leases | 9.85 | 2.36 | 22.91 | 30.36 | 29.3 | 12.41 |
Long-Term Unearned Revenue | 80.74 | 88.17 | 94.64 | 106.31 | 100.18 | 67.6 |
Long-Term Deferred Tax Liabilities | 31 | 31.94 | 34.74 | 37.44 | 33.9 | 30.26 |
Other Long-Term Liabilities | 18.42 | 39.76 | 84.78 | 88.07 | 0.65 | - |
Total Liabilities | 1,044 | 1,171 | 1,494 | 1,579 | 1,680 | 1,506 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 784.39 | 791.93 | 791.93 | 791.93 | 791.93 | 791.93 |
Additional Paid-In Capital | 664.12 | 681.59 | 653.84 | 653.84 | 733.84 | 766.15 |
Retained Earnings | 587.74 | 738.99 | 1,069 | 1,438 | 1,518 | 1,944 |
Treasury Stock | - | -25 | -25 | - | - | - |
Comprehensive Income & Other | 0.28 | 0.28 | 0.45 | 0.65 | 0.99 | 1.19 |
Total Common Equity | 2,037 | 2,188 | 2,490 | 2,884 | 3,044 | 3,503 |
Minority Interest | 79.83 | 82.82 | 116.35 | 133.81 | 145.85 | 59.25 |
Shareholders' Equity | 2,116 | 2,271 | 2,606 | 3,018 | 3,190 | 3,562 |
Total Liabilities & Equity | 3,160 | 3,442 | 4,100 | 4,597 | 4,870 | 5,068 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 673.01 | 684.31 | 948.01 | 992.65 | 1,087 | 912.11 |
Net Cash (Debt) | -270.32 | -217.11 | -407 | -293.18 | -494.6 | -532.48 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -0.35 | -0.28 | -0.52 | -0.37 | -0.62 | -0.67 |
Filing Date Shares Outstanding | 775.79 | 784.39 | 784.39 | 791.93 | 791.93 | 791.93 |
Total Common Shares Outstanding | 775.79 | 784.39 | 784.39 | 791.93 | 791.93 | 791.93 |
Working Capital | 445.43 | 538.84 | 801.01 | 1,140 | 867.92 | 640.59 |
Book Value Per Share | 2.63 | 2.79 | 3.17 | 3.64 | 3.84 | 4.42 |
Tangible Book Value | 1,734 | 1,875 | 2,039 | 2,390 | 2,518 | 2,347 |
Tangible Book Value Per Share | 2.24 | 2.39 | 2.60 | 3.02 | 3.18 | 2.96 |
Buildings | - | 1,862 | 1,911 | 1,865 | 1,686 | 1,326 |
Machinery | - | 888.61 | 924.43 | 933.15 | 906.77 | 809.92 |
Construction In Progress | - | 2.18 | 0.7 | 4.99 | 145.94 | 472.4 |